 |
Video: What is a Stock Split?
|
 |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. Co. is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. According to our CARA split history records, CARA has had 1 split. | |
 |

CARA (CARA) has 1 split in our CARA split history database. The split for CARA took place on December 31, 2024. This was a 1 for 12 reverse split, meaning for each 12 shares of CARA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.
When a company such as CARA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CARA split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CARA shares, starting with a $10,000 purchase of CARA, presented on a split-history-adjusted basis factoring in the complete CARA split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/21/2015 |
|
End date: |
04/15/2025 |
|
Start price/share: |
$189.48 |
|
End price/share: |
$5.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.19% |
|
Average Annual Total Return: |
-30.70% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$280.77 |
|
Years: |
9.74 |
|
|
 |
Date |
Ratio |
12/31/2024 | 1 for 12 |
|
 |